Daisuke Taniguchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Daisuke Taniguchi has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Nobutaka Hattori
Department of Neurology, Faculty of Medicine, Juntendo University, Tokyo 113-8421, Japan
6 shared publications - Manabu Funayama
Department of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan
3 shared publications Yuanzhe Li
Department of Neurology Juntendo University Graduate School of Medicine Bunkyo‐ku Tokyo Japan
3 shared publicationsKenya Nishioka
Department of Neurology Juntendo University Graduate School of Medicine Bunkyo‐ku Tokyo Japan
2 shared publicationsKo Tsuyama
Department of Neurology Juntendo University Graduate School of Medicine Bunkyo‐ku Tokyo Japan
2 shared publications- Takao Urabe
Department of Neurology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan
2 shared publications
Latest Publications
- 26 August 2026
- Published by Wiley in Neuropathology
- Vol. 46 (5)
Astrocyte‐Predominant Tau Pathology in a Patient With VCP R191Q Variant
Variants in the valosin‐containing protein (VCP) gene cause multisystem proteinopathy, typically characterized by TDP‐43 pathology. However, there are few reports describing tau pathology in VCP variant carriers. Here, we report a Japanese woman carrying a heterozygous VCP R191Q variant, who developed progressive muscle weakness, frontotemporal dementia, and parkinsonism beginning in her mid‐forties and died at the age of 61. Neuropathological examination demonstrated FTLD‐TDP type D pathology involving the frontal and temporal cortices, limbic structures, brainstem, spinal cord, and skeletal muscle. In addition, a distinct pattern of tau pathology was identified, predominantly in astrocytes and extending from the lower brainstem throughout the spinal cord. Tau aggregates were distributed in perivascular, subpial, and central gray matter, with a rostrocaudal distribution. Immunohistochemistry and confocal microscopy demonstrated colocalization of 3‐repeat (3R) and 4‐repeat (4R) tau within astrocytes, with predominance of 3R tau. Western blot analysis confirmed these findings and showed a tau banding pattern similar to that in Alzheimer's disease. These features differ from those observed in disorders with astrocytic tau pathology, such as cervical spondylotic myelopathy, chronic traumatic encephalopathy, and aging‐related tau astrogliopathy, which are typically characterized by predominance of 4R tau and minimal or absent 3R tau involvement. They also differ from the neuronal tau pathology observed in the frontotemporal cortex in patients with the VCP D395G variant. This case expands the neuropathological spectrum of VCP‐related diseases and suggests a possible association between VCP variants and pathological tau aggregation.
- 26 August 2026
- Published by Wiley in Neuropathology
- Vol. 46 (5)
Astrocyte‐Predominant Tau Pathology in a Patient With VCP R191Q Variant
Variants in the valosin‐containing protein (VCP) gene cause multisystem proteinopathy, typically characterized by TDP‐43 pathology. However, there are few reports describing tau pathology in VCP variant carriers. Here, we report a Japanese woman carrying a heterozygous VCP R191Q variant, who developed progressive muscle weakness, frontotemporal dementia, and parkinsonism beginning in her mid‐forties and died at the age of 61. Neuropathological examination demonstrated FTLD‐TDP type D pathology involving the frontal and temporal cortices, limbic structures, brainstem, spinal cord, and skeletal muscle. In addition, a distinct pattern of tau pathology was identified, predominantly in astrocytes and extending from the lower brainstem throughout the spinal cord. Tau aggregates were distributed in perivascular, subpial, and central gray matter, with a rostrocaudal distribution. Immunohistochemistry and confocal microscopy demonstrated colocalization of 3‐repeat (3R) and 4‐repeat (4R) tau within astrocytes, with predominance of 3R tau. Western blot analysis confirmed these findings and showed a tau banding pattern similar to that in Alzheimer's disease. These features differ from those observed in disorders with astrocytic tau pathology, such as cervical spondylotic myelopathy, chronic traumatic encephalopathy, and aging‐related tau astrogliopathy, which are typically characterized by predominance of 4R tau and minimal or absent 3R tau involvement. They also differ from the neuronal tau pathology observed in the frontotemporal cortex in patients with the VCP D395G variant. This case expands the neuropathological spectrum of VCP‐related diseases and suggests a possible association between VCP variants and pathological tau aggregation.
- Open Access
- 24 April 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (4) , e71388
Decreased Myocardial 123I‐MIBG Uptake Without Sympathetic Denervation: An Autopsy Report of Autoimmune Autonomic Ganglionopathy
Introduction: Autoimmune autonomic ganglionopathy (AAG) is a rare disorder characterized by widespread autonomic failure due to antibodies targeting the ganglionic nicotinic acetylcholine receptor (gAChR). Although the clinical manifestations of AAG have been widely reported, autopsy findings in human cases remain undocumented. Methods: We examined the clinical course, imaging data, and autopsy findings of a patient with AAG who survived for 14 years. Clinical symptoms, cardiac MIBG scintigraphy results, treatment response, and histological features of sympathetic ganglia and cardiac nerve fibers were analyzed. Results: The patient initially showed markedly reduced MIBG cardiac uptake, which improved with intravenous immunoglobulin therapy. After a prolonged clinical course with recurrent infections and nutritional decline, he died at age 78. Autopsy revealed preserved thoracic sympathetic ganglia and intact postganglionic sympathetic fibers in the heart. Mild perivascular lymphocytic infiltration was observed, but no neuronophagia or dense inflammatory infiltrates. Phosphorylated α‐synuclein was absent in the central and peripheral nervous systems. The enteric plexus was preserved, without overt neuronal loss. Age‐associated tau pathology was confined to the entorhinal cortex. Conclusion: Despite functional sympathetic impairment evident in reduced MIBG uptake and severe gastrointestinal dysmotility, there was no histologic evidence of sympathetic nerve degeneration or neuronal loss in the enteric plexus, supporting a postsynaptic channelopathy mechanism in AAG. The mild inflammation observed may reflect systemic illness rather than primary autoimmune pathology. This is the first report correlating longitudinal clinical data, imaging, and postmortem pathology in AAG.
- 24 April 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (4) , e71388
Open AccessDecreased Myocardial 123I‐MIBG Uptake Without Sympathetic Denervation: An Autopsy Report of Autoimmune Autonomic Ganglionopathy
Introduction: Autoimmune autonomic ganglionopathy (AAG) is a rare disorder characterized by widespread autonomic failure due to antibodies targeting the ganglionic nicotinic acetylcholine receptor (gAChR). Although the clinical manifestations of AAG have been widely reported, autopsy findings in human cases remain undocumented. Methods: We examined the clinical course, imaging data, and autopsy findings of a patient with AAG who survived for 14 years. Clinical symptoms, cardiac MIBG scintigraphy results, treatment response, and histological features of sympathetic ganglia and cardiac nerve fibers were analyzed. Results: The patient initially showed markedly reduced MIBG cardiac uptake, which improved with intravenous immunoglobulin therapy. After a prolonged clinical course with recurrent infections and nutritional decline, he died at age 78. Autopsy revealed preserved thoracic sympathetic ganglia and intact postganglionic sympathetic fibers in the heart. Mild perivascular lymphocytic infiltration was observed, but no neuronophagia or dense inflammatory infiltrates. Phosphorylated α‐synuclein was absent in the central and peripheral nervous systems. The enteric plexus was preserved, without overt neuronal loss. Age‐associated tau pathology was confined to the entorhinal cortex. Conclusion: Despite functional sympathetic impairment evident in reduced MIBG uptake and severe gastrointestinal dysmotility, there was no histologic evidence of sympathetic nerve degeneration or neuronal loss in the enteric plexus, supporting a postsynaptic channelopathy mechanism in AAG. The mild inflammation observed may reflect systemic illness rather than primary autoimmune pathology. This is the first report correlating longitudinal clinical data, imaging, and postmortem pathology in AAG.
- Open Access
- 28 January 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1715911
Spontaneous tauopathy with parkinsonism in an aged cynomolgus macaque
Introduction: Aged non-human primates have been reported to develop tau pathology; however, most studies lack evidence of any associated neurological symptoms. To determine whether spontaneous tauopathy in cynomolgus macaques manifests with neurological symptoms, we evaluated a symptomatic aged monkey (Monkey T) alongside an asymptomatic control (Monkey A). Methods: Two male cynomolgus macaques, aged 33–34 years old at the time of necropsy, were examined. They were evaluated using comprehensive behavioral, pathological, and genetic analyses. Results: Monkey T exhibited progressive neurological symptoms for approximately two years prior to euthanasia, including tremors, nuchal dystonia, and a flexed posture, whereas Monkey A showed no abnormalities. Monkey T demonstrated persistent tremors (6.9 ± 0.7 Hz) and reduced daily motor activity, with modest improvement following L-DOPA administration. Neuropathological evaluation revealed brainstem atrophy and mild depigmentation of the substantia nigra and locus coeruleus. Extensive phosphorylated tau accumulation was observed throughout the brainstem tegmentum, including neurofibrillary tangles, threads, coiled bodies, and astrocytic inclusions. All tau lesions were positive for 4-repeat tau and negative for 3-repeat tau. MAPT sequencing identified four non-pathogenic 3′UTR variants differing between the two monkeys. Isoform analysis showed balanced 3R/4R tau expression in Monkey A but an approximately 1.3-fold increase in 4R tau in Monkey T. Discussion: The parkinsonian symptoms observed in Monkey T were more likely attributable to widespread tau pathology in the brainstem rather than overt degeneration of the nigrostriatal dopaminergic system. This case represents a rare instance of spontaneous tauopathy in an aged cynomolgus macaque, a condition that is extremely difficult to reproduce experimentally. These findings highlight the potential value of cynomolgus macaques as a relevant model for studying sporadic tauopathies, including tau seeding mechanisms.
- 28 January 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1715911
Open AccessSpontaneous tauopathy with parkinsonism in an aged cynomolgus macaque
Introduction: Aged non-human primates have been reported to develop tau pathology; however, most studies lack evidence of any associated neurological symptoms. To determine whether spontaneous tauopathy in cynomolgus macaques manifests with neurological symptoms, we evaluated a symptomatic aged monkey (Monkey T) alongside an asymptomatic control (Monkey A). Methods: Two male cynomolgus macaques, aged 33–34 years old at the time of necropsy, were examined. They were evaluated using comprehensive behavioral, pathological, and genetic analyses. Results: Monkey T exhibited progressive neurological symptoms for approximately two years prior to euthanasia, including tremors, nuchal dystonia, and a flexed posture, whereas Monkey A showed no abnormalities. Monkey T demonstrated persistent tremors (6.9 ± 0.7 Hz) and reduced daily motor activity, with modest improvement following L-DOPA administration. Neuropathological evaluation revealed brainstem atrophy and mild depigmentation of the substantia nigra and locus coeruleus. Extensive phosphorylated tau accumulation was observed throughout the brainstem tegmentum, including neurofibrillary tangles, threads, coiled bodies, and astrocytic inclusions. All tau lesions were positive for 4-repeat tau and negative for 3-repeat tau. MAPT sequencing identified four non-pathogenic 3′UTR variants differing between the two monkeys. Isoform analysis showed balanced 3R/4R tau expression in Monkey A but an approximately 1.3-fold increase in 4R tau in Monkey T. Discussion: The parkinsonian symptoms observed in Monkey T were more likely attributable to widespread tau pathology in the brainstem rather than overt degeneration of the nigrostriatal dopaminergic system. This case represents a rare instance of spontaneous tauopathy in an aged cynomolgus macaque, a condition that is extremely difficult to reproduce experimentally. These findings highlight the potential value of cynomolgus macaques as a relevant model for studying sporadic tauopathies, including tau seeding mechanisms.
- Open Access
- 6 July 2025
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 15 (5) , 1019-1023
Diffuse putaminal degeneration without iron deposition in multiple system atrophy
Background: Multiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by parkinsonism, cerebellar ataxia, and autonomic dysfunction. Putaminal hypointensities on T2 magnetic resonance imaging (MRI) are commonly observed in the parkinsonian variant of MSA (MSA-P). Objective: To report a neuropathologically confirmed case of MSA-P with an atypical MRI presentation, characterized by progressive T2 hyperintensity in the putamen, without significant iron accumulation. Methods: We present the clinical course, imaging findings, and neuropathological results of a 57-year-old woman with MSA-P. Diagnostic evaluations included serial brain MRI, cerebrospinal fluid analysis, magnetic resonance spectroscopy, and post-mortem pathological examination. Results: The patient initially presented with L-dopa-responsive bradykinesia and right-dominant rigidity, followed by progressive motor decline, orthostatic hypotension, and urinary retention. Serial T2-weighted MRI revealed diffuse and progressively increasing hyperintensity in the putamen, accompanied by atrophy predominantly on the left side. Autopsy confirmed the diagnosis of MSA, revealing severe neuronal loss, marked gliosis, and abundant glial cytoplasmic inclusions in the putamen, with only mild iron deposition as shown by Prussian blue staining. Conclusions: This case demonstrates that severe putaminal neurodegeneration in advanced MSA can be associated with progressive T2 hyperintensity on MRI, reflected by the absence of substantial iron deposition. These findings indicate that iron-independent mechanisms contribute to the pathophysiology of MSA-related putaminal damage in patients with MSA.
- 6 July 2025
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 15 (5) , 1019-1023
Open AccessDiffuse putaminal degeneration without iron deposition in multiple system atrophy
Background: Multiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by parkinsonism, cerebellar ataxia, and autonomic dysfunction. Putaminal hypointensities on T2 magnetic resonance imaging (MRI) are commonly observed in the parkinsonian variant of MSA (MSA-P). Objective: To report a neuropathologically confirmed case of MSA-P with an atypical MRI presentation, characterized by progressive T2 hyperintensity in the putamen, without significant iron accumulation. Methods: We present the clinical course, imaging findings, and neuropathological results of a 57-year-old woman with MSA-P. Diagnostic evaluations included serial brain MRI, cerebrospinal fluid analysis, magnetic resonance spectroscopy, and post-mortem pathological examination. Results: The patient initially presented with L-dopa-responsive bradykinesia and right-dominant rigidity, followed by progressive motor decline, orthostatic hypotension, and urinary retention. Serial T2-weighted MRI revealed diffuse and progressively increasing hyperintensity in the putamen, accompanied by atrophy predominantly on the left side. Autopsy confirmed the diagnosis of MSA, revealing severe neuronal loss, marked gliosis, and abundant glial cytoplasmic inclusions in the putamen, with only mild iron deposition as shown by Prussian blue staining. Conclusions: This case demonstrates that severe putaminal neurodegeneration in advanced MSA can be associated with progressive T2 hyperintensity on MRI, reflected by the absence of substantial iron deposition. These findings indicate that iron-independent mechanisms contribute to the pathophysiology of MSA-related putaminal damage in patients with MSA.
- Open Access
- 30 July 2024
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 3 (8) , pgae319
CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca2+ homeostasis
CHCHD2 and CHCHD10, linked to Parkinson's disease and amyotrophic lateral sclerosis-frontotemporal dementia (ALS), respectively, are mitochondrial intermembrane proteins that form a heterodimer. This study aimed to investigate the impact of the CHCHD2 P14L variant, implicated in ALS, on mitochondrial function and its subsequent effects on cellular homeostasis. The missense variant of CHCHD2, P14L, found in a cohort of patients with ALS, mislocalized CHCHD2 to the cytoplasm, leaving CHCHD10 in the mitochondria. Drosophila lacking the CHCHD2 ortholog exhibited mitochondrial degeneration. In contrast, human CHCHD2 P14L, but not wild-type human CHCHD2, failed to suppress this degeneration, suggesting that P14L is a pathogenic variant. The mitochondrial Ca2+ buffering capacity was reduced in Drosophila neurons expressing human CHCHD2 P14L. The altered Ca2+-buffering phenotype was also observed in cultured human neuroblastoma SH-SY5Y cells expressing CHCHD2 P14L. In these cells, transient elevation of cytoplasmic Ca2+ facilitated the activation of calpain and caspase-3, accompanied by the processing and insolubilization of TDP-43. These observations suggest that CHCHD2 P14L causes abnormal Ca2+ dynamics and TDP-43 aggregation, reflecting the pathophysiology of ALS.
- 30 July 2024
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 3 (8) , pgae319
Open AccessCHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca2+ homeostasis
CHCHD2 and CHCHD10, linked to Parkinson's disease and amyotrophic lateral sclerosis-frontotemporal dementia (ALS), respectively, are mitochondrial intermembrane proteins that form a heterodimer. This study aimed to investigate the impact of the CHCHD2 P14L variant, implicated in ALS, on mitochondrial function and its subsequent effects on cellular homeostasis. The missense variant of CHCHD2, P14L, found in a cohort of patients with ALS, mislocalized CHCHD2 to the cytoplasm, leaving CHCHD10 in the mitochondria. Drosophila lacking the CHCHD2 ortholog exhibited mitochondrial degeneration. In contrast, human CHCHD2 P14L, but not wild-type human CHCHD2, failed to suppress this degeneration, suggesting that P14L is a pathogenic variant. The mitochondrial Ca2+ buffering capacity was reduced in Drosophila neurons expressing human CHCHD2 P14L. The altered Ca2+-buffering phenotype was also observed in cultured human neuroblastoma SH-SY5Y cells expressing CHCHD2 P14L. In these cells, transient elevation of cytoplasmic Ca2+ facilitated the activation of calpain and caspase-3, accompanied by the processing and insolubilization of TDP-43. These observations suggest that CHCHD2 P14L causes abnormal Ca2+ dynamics and TDP-43 aggregation, reflecting the pathophysiology of ALS.
- Open Access
Possible Neuroprotective Effects of l-Carnitine on White-Matter Microstructural Damage and Cognitive Decline in Hemodialysis Patients
Although l-carnitine alleviated white-matter lesions in an experimental study, the treatment effects of l-carnitine on white-matter microstructural damage and cognitive decline in hemodialysis patients are unknown. Using novel diffusion magnetic resonance imaging (dMRI) techniques, white-matter microstructural changes together with cognitive decline in hemodialysis patients and the effects of l-carnitine on such disorders were investigated. Fourteen hemodialysis patients underwent dMRI and laboratory and neuropsychological tests, which were compared across seven patients each in two groups according to duration of l-carnitine treatment: (1) no or short-term l-carnitine treatment (NSTLC), and (2) long-term l-carnitine treatment (LTLC). Ten age- and sex-matched controls were enrolled. Compared to controls, microstructural disorders of white matter were widely detected on dMRI of patients. An autopsy study of one patient in the NSTLC group showed rarefaction of myelinated fibers in white matter. With LTLC, microstructural damage on dMRI was alleviated along with lower levels of high-sensitivity C-reactive protein and substantial increases in carnitine levels. The LTLC group showed better achievement on trail making test A, which was correlated with amelioration of disorders in some white-matter tracts. Novel dMRI tractography detected abnormalities of white-matter tracts after hemodialysis. Long-term treatment with l-carnitine might alleviate white-matter microstructural damage and cognitive impairment in hemodialysis patients.
Open AccessPossible Neuroprotective Effects of l-Carnitine on White-Matter Microstructural Damage and Cognitive Decline in Hemodialysis Patients
Although l-carnitine alleviated white-matter lesions in an experimental study, the treatment effects of l-carnitine on white-matter microstructural damage and cognitive decline in hemodialysis patients are unknown. Using novel diffusion magnetic resonance imaging (dMRI) techniques, white-matter microstructural changes together with cognitive decline in hemodialysis patients and the effects of l-carnitine on such disorders were investigated. Fourteen hemodialysis patients underwent dMRI and laboratory and neuropsychological tests, which were compared across seven patients each in two groups according to duration of l-carnitine treatment: (1) no or short-term l-carnitine treatment (NSTLC), and (2) long-term l-carnitine treatment (LTLC). Ten age- and sex-matched controls were enrolled. Compared to controls, microstructural disorders of white matter were widely detected on dMRI of patients. An autopsy study of one patient in the NSTLC group showed rarefaction of myelinated fibers in white matter. With LTLC, microstructural damage on dMRI was alleviated along with lower levels of high-sensitivity C-reactive protein and substantial increases in carnitine levels. The LTLC group showed better achievement on trail making test A, which was correlated with amelioration of disorders in some white-matter tracts. Novel dMRI tractography detected abnormalities of white-matter tracts after hemodialysis. Long-term treatment with l-carnitine might alleviate white-matter microstructural damage and cognitive impairment in hemodialysis patients.
- Open Access
- 7 December 2017
- Published by Springer Nature in BMC Neurology
- Vol. 17 (1) , 210
Widespread enlarged perivascular spaces associated with dementia and focal brain dysfunction: case report
Enlarged perivascular spaces (PVS) are common magnetic resonance imaging (MRI) findings, whereas widespread enlarged PVS are extremely rare. Although most patients with widespread enlarged PVS remain asymptomatic, some develop neurological dysfunctions; however, it remains unclear whether these are the consequence of widespread enlarged PVS. A 64-year-old female patient developed consciousness disturbance, cognitive dysfunctions, fluent aphasia, agraphia, acalculia, and left-right disorientation after suffering from bronchopneumonia. Brain MRI revealed unusually widespread enlarged PVS predominantly in the left cerebral hemisphere. Following bronchopneumonia treatment, her cognitive dysfunction, fluent aphasia, agraphia, acalculia, and left-right disorientation persisted despite improvement of her general condition. Furthermore, the hypoperfusion area on single photon emission computed tomography and slow wave sites on electroencephalography were consistent with the location of enlarged PVS, indicating that severe enlarged PVS impaired focal brain functions. This case suggested that widespread enlarged PVS could be a potential cause of neurological deficits. We propose that impaired perivascular circulation due to enlarged PVS might lead to focal brain dysfunction.
- 7 December 2017
- Published by Springer Nature in BMC Neurology
- Vol. 17 (1) , 210
Open AccessWidespread enlarged perivascular spaces associated with dementia and focal brain dysfunction: case report
Enlarged perivascular spaces (PVS) are common magnetic resonance imaging (MRI) findings, whereas widespread enlarged PVS are extremely rare. Although most patients with widespread enlarged PVS remain asymptomatic, some develop neurological dysfunctions; however, it remains unclear whether these are the consequence of widespread enlarged PVS. A 64-year-old female patient developed consciousness disturbance, cognitive dysfunctions, fluent aphasia, agraphia, acalculia, and left-right disorientation after suffering from bronchopneumonia. Brain MRI revealed unusually widespread enlarged PVS predominantly in the left cerebral hemisphere. Following bronchopneumonia treatment, her cognitive dysfunction, fluent aphasia, agraphia, acalculia, and left-right disorientation persisted despite improvement of her general condition. Furthermore, the hypoperfusion area on single photon emission computed tomography and slow wave sites on electroencephalography were consistent with the location of enlarged PVS, indicating that severe enlarged PVS impaired focal brain functions. This case suggested that widespread enlarged PVS could be a potential cause of neurological deficits. We propose that impaired perivascular circulation due to enlarged PVS might lead to focal brain dysfunction.
- Open Access
- 26 September 2017
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 11 (1) , 281
Deep cerebral venous thrombosis mimicking influenza-associated acute necrotizing encephalopathy: a case report
Acute necrotizing encephalopathy is one of the most devastating neurological complications of influenza virus infection. Acute necrotizing encephalopathy preferentially affects the thalamus bilaterally, as does deep cerebral venous thrombosis, which can lead to misdiagnosis. A 52-year-old Japanese woman infected with seasonal influenza B virus presented to the emergency care unit in our hospital with progressive alteration of her level of consciousness. Bilateral thalamic lesions were demonstrated by magnetic resonance imaging, leading to a tentative diagnosis of acute necrotizing encephalopathy. However, she had deep cerebral venous thrombosis, and the presence of diminished signal and enlargement of deep cerebral veins on T2*-weighted imaging contributed to a revised diagnosis of deep cerebral venous thrombosis. Anticoagulant therapy was initiated, leading to her gradual recovery, with recanalization of the deep venous system and straight sinus. To the best of our knowledge, these results represent the first report of deep cerebral venous thrombosis associated with influenza infection. It is clinically important to recognize that deep cerebral venous thrombosis, although rare, might be one of the neurological complications of influenza infection. In the presence of bilateral thalamic lesions in patients with influenza infection, deep cerebral venous thrombosis should be considered in addition to acute necrotizing encephalopathy. Delays in diagnosis and commencement of anticoagulant therapy can lead to unfavorable outcomes.
- 26 September 2017
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 11 (1) , 281
Open AccessDeep cerebral venous thrombosis mimicking influenza-associated acute necrotizing encephalopathy: a case report
Acute necrotizing encephalopathy is one of the most devastating neurological complications of influenza virus infection. Acute necrotizing encephalopathy preferentially affects the thalamus bilaterally, as does deep cerebral venous thrombosis, which can lead to misdiagnosis. A 52-year-old Japanese woman infected with seasonal influenza B virus presented to the emergency care unit in our hospital with progressive alteration of her level of consciousness. Bilateral thalamic lesions were demonstrated by magnetic resonance imaging, leading to a tentative diagnosis of acute necrotizing encephalopathy. However, she had deep cerebral venous thrombosis, and the presence of diminished signal and enlargement of deep cerebral veins on T2*-weighted imaging contributed to a revised diagnosis of deep cerebral venous thrombosis. Anticoagulant therapy was initiated, leading to her gradual recovery, with recanalization of the deep venous system and straight sinus. To the best of our knowledge, these results represent the first report of deep cerebral venous thrombosis associated with influenza infection. It is clinically important to recognize that deep cerebral venous thrombosis, although rare, might be one of the neurological complications of influenza infection. In the presence of bilateral thalamic lesions in patients with influenza infection, deep cerebral venous thrombosis should be considered in addition to acute necrotizing encephalopathy. Delays in diagnosis and commencement of anticoagulant therapy can lead to unfavorable outcomes.